Previous 10 | Next 10 |
Gainers: Camber Energy (NYSEMKT: CEI ) +107% . Acacia Communications (NASDAQ: ACIA ) +35% . Electrameccanica Vehicles (NASDAQ: SOLO ) +26% . Xenetic Biosciences (NASDAQ: XBIO ) +16% . iFresh Inc. (NASDAQ: IFMK ) +15% . Atreca (NASDAQ: BCEL ) +15% . Pareteum Corporation (NASDAQ:...
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on therapeutics for human aging, announced today that founder and CEO Michael D. West, Ph.D. will present at Ending Age-Related Diseases: Investment Prospects & Advances in Research , fr...
AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on therapeutics for human aging, will participate at Biotech Investing in Longevity , an evening event from Aikora Health and Foresight Institute , on Wednesday, May 1, in San Francisco....
AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on therapeutics for human aging, announced today that the company will participate at Master Investor Show 2019 , in association with Fidelity International , on Saturday, April 6 in Londo...
AgeX Therapeutics (NYSEMKT: AGE ): Q4 GAAP EPS of -$0.09. More news on: AgeX Therapeutics, Inc., Earnings news and commentary, , Read more ...
Ends 2018 with triad of innovative cell therapy technologies: UniverCyte™ for immune tolerance, PureStem ® for cell derivation and manufacturing, and HyStem ® for cell delivery Potential to generate any human cell type with clinical and commercial friendly characteri...
AgeX Therapeutics , Inc. (“AgeX”, NYSE American: AGE), a biotechnology company focused on innovative therapeutics for human aging, announced today that it has received $4.5 million from the exercise of AgeX common stock warrants. Warrant holders purchased a total of 1,800,000 ...
AgeX Therapeutics , Inc. (NYSE American: AGE), a biotechnology company focused on innovative therapeutics for human aging, announced today that the company will present in multiple sessions at Undoing Aging 2019 , March 28-30 in Berlin, Germany. Details of the company’s particip...
LifeMap Sciences (“ LifeMap ”), a subsidiary of AgeX Therapeutics , Inc. (NYSE American: AGE), announced today that it has entered into a collaboration with iCarbonX Research Shenzhen , enabling iCarbonX to leverage LifeMap’s GeneCards ® Suite platform in product...
ALAMEDA, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today provided a business update which included information on AgeX Therapeutics, Inc. (AgeX) (NYSE American: AGE) and BioT...
News, Short Squeeze, Breakout and More Instantly...
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024 Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024; IND submission to the FDA for the initiation of a Phas...
ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended Decembe...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...